Ryan Specialty Stock Price, News & Analysis (NYSE:RYAN) $45.43 +0.03 (+0.07%) (As of 12:33 PM ET) Add Compare Share Share Today's Range$45.23▼$45.5750-Day Range$43.15▼$49.3352-Week Range$35.10▼$50.64Volume127,519 shsAverage Volume661,635 shsMarket Capitalization$11.82 billionP/E Ratio96.66Dividend YieldN/APrice Target$51.14 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Ryan Specialty MarketRank™ Stock AnalysisAnalyst RatingHold2.43 Rating ScoreUpside/Downside12.4% Upside$51.14 Price TargetShort InterestBearish6.05% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingSelling Shares$471,656 Sold Last QuarterProj. Earnings Growth23.19%From $1.38 to $1.70 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.23 out of 5 starsFinance Sector465th out of 860 stocksInsurance Agents, Brokers, & Service Industry11th out of 16 stocks 3.2 Analyst's Opinion Consensus RatingRyan Specialty has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 3 buy ratings, 4 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $51.14, Ryan Specialty has a forecasted upside of 12.4% from its current price of $45.49.Amount of Analyst CoverageRyan Specialty has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.0 Short Interest Percentage of Shares Shorted6.05% of the float of Ryan Specialty has been sold short.Short Interest Ratio / Days to CoverRyan Specialty has a short interest ratio ("days to cover") of 9.1.Change versus previous monthShort interest in Ryan Specialty has recently decreased by 4.98%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldRyan Specialty does not currently pay a dividend.Dividend GrowthRyan Specialty does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RYAN. Previous Next 0.9 News and Social Media Coverage News SentimentRyan Specialty has a news sentiment score of -0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Finance companies.MarketBeat FollowsOnly 2 people have added Ryan Specialty to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Ryan Specialty insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $471,656.00 in company stock.Percentage Held by Insiders54.51% of the stock of Ryan Specialty is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 34.09% of the stock of Ryan Specialty is held by institutions. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Ryan Specialty are expected to grow by 23.19% in the coming year, from $1.38 to $1.70 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Ryan Specialty is 96.79, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 113.81.Price to Earnings Ratio vs. SectorThe P/E ratio of Ryan Specialty is 96.79, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 46.25.Price to Book Value per Share RatioRyan Specialty has a P/B Ratio of 12.57. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Ryan Specialty Stock (NYSE:RYAN)Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company serves commercial, industrial, institutional, and government sectors. Ryan Specialty Holdings, Inc. was founded in 2010 and is headquartered in Chicago, Illinois.Read More RYAN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RYAN Stock News HeadlinesNovember 22, 2023 | americanbankingnews.comThe Goldman Sachs Group Downgrades Ryan Specialty (NYSE:RYAN) to NeutralNovember 20, 2023 | msn.comGoldman Sachs Downgrades Ryan Specialty Holdings Inc (RYAN)November 29, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 20, 2023 | markets.businessinsider.comWhat 4 Analyst Ratings Have To Say About Ryan Specialty HldgsNovember 14, 2023 | msn.comRyan Bridge asks Nicky Styris' husband 'what's she like at home' amid 'iron fist' discussionNovember 6, 2023 | finance.yahoo.comRyan Specialty Holdings, Inc.'s (NYSE:RYAN) P/S Is On The MarkNovember 5, 2023 | msn.comDaisy Ridley Stars In ‘The Marsh King's Daughter', Meg Ryan's Rom-Com Return, ‘Priscilla' Expands – Specialty PreviewNovember 4, 2023 | finance.yahoo.comRyan Specialty Holdings, Inc. (NYSE:RYAN) Q3 2023 Earnings Call TranscriptNovember 29, 2023 | Tomorrow Investor (Ad)The Only Practical Solution to the World’s Looming Energy CrisisThere’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!November 3, 2023 | finance.yahoo.comRyan Specialty Group (RYAN) Meets Q3 Earnings EstimatesNovember 2, 2023 | finance.yahoo.comRyan Specialty Reports Third Quarter 2023 ResultsNovember 2, 2023 | finance.yahoo.comRyan Specialty Holdings Inc (RYAN) Reports 21.8% YoY Revenue Growth in Q3 2023November 1, 2023 | health.usnews.comRyan T. JohnsonNovember 1, 2023 | axios.comExclusive: Free Market Health raises $20M Series BNovember 1, 2023 | msn.comBMO Capital Downgrades Ryan Specialty Holdings Inc (RYAN)October 31, 2023 | finance.yahoo.comRyan Specialty Appoints to Its Board of Directors Anthony J. Kuczinski, Former President & CEO of Munich Re USOctober 31, 2023 | msn.comSpeciality insurance company Ryan Specialty to acquire AccuRiskOctober 30, 2023 | marketwatch.comRyan Specialty to Acquire AccuRisk HoldingsOctober 30, 2023 | bizjournals.comDoctors buy Glens Falls building to renovate as new speciality veterinary practiceOctober 30, 2023 | msn.comRyan Specialty Holdings downgraded at BMO on negative seasonalityOctober 30, 2023 | finance.yahoo.comRyan Specialty Signs Definitive Agreement To Acquire AccuRisk HoldingsOctober 30, 2023 | finance.yahoo.comAccuRisk Holdings to be Acquired by Ryan SpecialtyOctober 30, 2023 | msn.comChester County is getting a new DA. Both candidates are touting law enforcement changes — especially after Cavalcante’s escapeOctober 26, 2023 | finance.yahoo.comArthur J. Gallagher (AJG) Tops Q3 Earnings and Revenue EstimatesOctober 24, 2023 | nz.news.yahoo.comGotham Awards Nominations: ‘All Of Us Strangers’ Tops Movie List; Ryan Gosling Gets ‘Barbie’ Nom With Budget Caps RemovedOctober 24, 2023 | finance.yahoo.comRisk Strategies Acquires North Bay Business Unit of InterWest Insurance Services, Expands Wineries Specialty CapabilitiesOctober 19, 2023 | omaha.comOrthoNebraska expands services, walk-in care in Omaha metroSee More Headlines Receive RYAN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ryan Specialty and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/02/2023Today11/29/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Insurance agents, brokers, & service Sub-IndustryN/A SectorFinance Current SymbolNYSE:RYAN CUSIPN/A CIK1849253 Webryansg.com Phone312-784-6001FaxN/AEmployees3,850Year FoundedN/APrice Target and Rating Average Stock Price Target$51.14 High Stock Price Target$59.00 Low Stock Price Target$43.00 Potential Upside/Downside+12.5%Consensus RatingHold Rating Score (0-4)2.43 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)$0.47 Trailing P/E Ratio96.73 Forward P/E Ratio32.94 P/E GrowthN/ANet Income$61.05 million Net Margins9.18% Pretax Margin11.64% Return on Equity42.39% Return on Assets5.78% Debt Debt-to-Equity Ratio2.07 Current Ratio1.20 Quick Ratio1.20 Sales & Book Value Annual Sales$1.73 billion Price / Sales6.86 Cash Flow$1.66 per share Price / Cash Flow27.38 Book Value$3.62 per share Price / Book12.56Miscellaneous Outstanding Shares260,250,000Free Float118,388,000Market Cap$11.83 billion OptionableNot Optionable Beta0.46 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Patrick G. Ryan (Age 85)Chairman & CEO Comp: $4.48MMr. Timothy William Turner (Age 62)President & Director Comp: $3.97MMr. Jeremiah Rawlins Bickham (Age 37)Executive VP & CFO Comp: $1.62MMr. Mark Stephen Katz Esq. (Age 54)Executive VP, General Counsel & Corporate Secretary Comp: $1.56MMr. Brendan Martin Mulshine (Age 57)Executive VP & Chief Revenue Officer Comp: $1.74MMr. Kirk A. BehrensExecutive Vice President of Operations, Technology & Data AnalyticsMs. Janice M. HamiltonSenior VP, Controller & Chief Accounting OfficerMr. Bradley Eames Bodell B.S. (Age 57)Chief Information Officer Mr. Mark C. MelanderChief Administrative OfficerMr. Nicholas J. Mezick C.F.A.Director of Investor RelationsMore ExecutivesKey CompetitorsEquitableNYSE:EQHErie IndemnityNASDAQ:ERIEEnactNASDAQ:ACTBrown & BrownNYSE:BROWillis Towers Watson PublicNASDAQ:WTWView All CompetitorsInsiders & InstitutionsDeutsche Bank AGSold 2,193 shares on 11/24/2023Ownership: 0.002%Polar Capital Holdings PlcSold 37,500 shares on 11/22/2023Ownership: 0.495%Comerica BankBought 698 shares on 11/21/2023Ownership: 0.000%Jacobs Levy Equity Management Inc.Bought 245,827 shares on 11/17/2023Ownership: 0.446%Diversified Trust CoBought 1,300 shares on 11/17/2023Ownership: 0.005%View All Insider TransactionsView All Institutional Transactions RYAN Stock Analysis - Frequently Asked Questions Should I buy or sell Ryan Specialty stock right now? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ryan Specialty in the last twelve months. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" RYAN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RYAN, but not buy additional shares or sell existing shares. View RYAN analyst ratings or view top-rated stocks. What is Ryan Specialty's stock price target for 2024? 7 equities research analysts have issued twelve-month target prices for Ryan Specialty's shares. Their RYAN share price targets range from $43.00 to $59.00. On average, they predict the company's stock price to reach $51.14 in the next twelve months. This suggests a possible upside of 12.4% from the stock's current price. View analysts price targets for RYAN or view top-rated stocks among Wall Street analysts. How have RYAN shares performed in 2023? Ryan Specialty's stock was trading at $41.51 at the start of the year. Since then, RYAN stock has increased by 9.6% and is now trading at $45.49. View the best growth stocks for 2023 here. When is Ryan Specialty's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024. View our RYAN earnings forecast. How were Ryan Specialty's earnings last quarter? Ryan Specialty Holdings, Inc. (NYSE:RYAN) announced its quarterly earnings results on Thursday, November, 2nd. The company reported $0.32 earnings per share for the quarter, hitting the consensus estimate of $0.32. The business had revenue of $501.94 million for the quarter, compared to the consensus estimate of $500.92 million. Ryan Specialty had a net margin of 9.18% and a trailing twelve-month return on equity of 42.39%. What ETFs hold Ryan Specialty's stock? ETFs with the largest weight of Ryan Specialty (NYSE:RYAN) stock in their portfolio include SPDR S&P Insurance ETF (KIE), Invesco Dorsey Wright Financial Momentum ETF (PFI), Renaissance IPO ETF (IPO) and First Trust Multi-Manager Small Cap Opportunities ETF (MMSC).Nuveen ESG Small-Cap ETF (NUSC). When did Ryan Specialty IPO? (RYAN) raised $1.3 billion in an IPO on Thursday, July 22nd 2021. The company issued 56,918,278 shares at $22.00-$25.00 per share. Who are Ryan Specialty's major shareholders? Ryan Specialty's stock is owned by a variety of institutional and retail investors. Top institutional investors include Kayne Anderson Rudnick Investment Management LLC (3.92%), Artisan Partners Limited Partnership (1.09%), Blair William & Co. IL (1.02%), Morgan Stanley (0.81%), Victory Capital Management Inc. (0.69%) and Ameriprise Financial Inc. (0.57%). Insiders that own company stock include Brendan Martin Mulshine, Corp Onex, David P Bolger, Lisa Jo Paschal-Alcorn, Mark Stephen Katz, Michael D Ohalleran, Michael Thomas Vanacker, Nicholas Dominic Cortezi, Patrick G Ryan and Timothy William Turner. View institutional ownership trends. How do I buy shares of Ryan Specialty? Shares of RYAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NYSE:RYAN) was last updated on 11/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ryan Specialty Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.